Episode Player

Mo Li on PARP inhibitors

eBioMedicine in conversation with

eBioMedicine in conversation with
Mo Li on PARP inhibitors
Jul 04, 2024
The Lancet Group

Dr. Mo Li from Peking University Third Hospital discusses his publication "PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response".

Read the full article:
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00164-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv